- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Bev H. Lorell, M.D. (Beverly)
Events 21 results
Speaking Engagement
Webinar
October 24, 2024
Real-World Data for Clinical Trials: Brand New FDA Expectations for Use of Real-World Evidence for Regulatory Decision-Making
Conference
September 5, 2024
17th Annual King & Spalding Medical Device Summit
Conference
November 7, 2023
Pharmaceutical University 2023
Webinar
September 27, 2023
At Last! FDA Issues Final Guidance on Use of Real-World Evidence for Regulatory Decision-Making for Drug and Biological Products
Conference
September 7, 2023
16th Annual King & Spalding Medical Device Summit
Webinar
June 8, 2023
Are You Ready? The New FDA Requirement for Diversity Action Plans in Drug and Device Clinical Investigations
Webinar
November 30, 2022
Are You Prepared? FDA’s Proposed Rules to Modify Protection of Human Subjects and IRB Oversight
Conference
November 1, 2022
Pharmaceutical University 2022
Webinar
May 31, 2017
ClinicalTrials.gov – Navigating the New Rule and the Expansion of Public Disclosure of Your Clinical Trial Data
Conference
January 12, 2017
An Introduction to the 21st Century Cures Act
Conference
November 15, 2016
9th Annual King & Spalding Pharmaceutical University